Directory

>

Andy Scharenberg

avatar

Andy Scharenberg

Co-founder and Member, Board of Directors | MPM BioImpact

Washington, Seattle, United States

View contact details (it's free)

Andy Scharenberg

Summary

Andy Scharenberg is a distinguished physician, scientist, and entrepreneur based in Seattle, Washington. As the CEO of Umoja Biopharma, he is at the forefront of developing innovative therapies using CAR T-cell technology to combat cancer, particularly in pediatric patients. With a strong background in immunology and cell editing technology, Andy has held several key leadership positions, including Chief Scientific Officer at Cellectis and Casebia Therapeutics. His expertise extends to serving on the Scientific Advisory Board of bluebird bio and co-founding Generation Bio, where he plays a pivotal role in steering scientific direction. With over two decades in the industry, Andy combines his medical training with a passion for entrepreneurship, making significant contributions to the field of biopharma. His experience spans both corporate and startup environments, reflecting a versatile career dedicated to advancing healthcare solutions. Andy's work is characterized by a commitment to innovation and improving patient outcomes through cutting-edge technology.

General

Generalist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Sustainability

Innovation

Organisational experience

Startup Experience

Corporate Experience

Andy Scharenberg

Work Experience

💼

Chief Executive Officer at

Umoja Biopharma

November 2019 - Present

Logos provided by Logo.dev

Andy Scharenberg

Education

University of North Carolina School of Medicine, MD, Medicine

January 1991 - January 1993

Frequently Asked Questions about Andy Scharenberg

What is Andy Scharenberg email address?

Andy Scharenberg's primary email address is ************@generationbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Andy Scharenberg work for?

Andy Scharenberg is a Co-founder and Member, Board of Directors at MPM BioImpact.

Where Andy Scharenberg graduated from?

Andy Scharenberg holds a degree in null from University of North Carolina School of Medicine.

How can I directly contact Andy Scharenberg?

To contact Andy Scharenberg directly, you can use the email address ************@generationbio.com. Complete contact information is available upon registration with Muraena.

Who is Andy Scharenberg?

Andy Scharenberg is a distinguished physician, scientist, and entrepreneur based in Seattle, Washington. As the CEO of Umoja Biopharma, he is at the forefront of developing innovative therapies using CAR T-cell technology to combat cancer, particularly in pediatric patients. With a strong background in immunology and cell editing technology, Andy has held several key leadership positions, including Chief Scientific Officer at Cellectis and Casebia Therapeutics. His expertise extends to serving on the Scientific Advisory Board of bluebird bio and co-founding Generation Bio, where he plays a pivotal role in steering scientific direction. With over two decades in the industry, Andy combines his medical training with a passion for entrepreneurship, making significant contributions to the field of biopharma. His experience spans both corporate and startup environments, reflecting a versatile career dedicated to advancing healthcare solutions. Andy's work is characterized by a commitment to innovation and improving patient outcomes through cutting-edge technology.

Andy`s contact details

mail

************@generationbio.com

******************@umoja-biopharma.com

********@u.washington.edu

************@bluebirdbio.com

******@uw.edu

******@washington.edu

************@mpmcapital.com

Colleagues

avatar
Shawn Johnson

Post-Baccalaureate Research Fellow

avatar
Joseph Bolen

Head of Oncology Research

View Contact details (it's free)
Request Profile Removal